0001178913-18-003173.txt : 20181220 0001178913-18-003173.hdr.sgml : 20181220 20181220082905 ACCESSION NUMBER: 0001178913-18-003173 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181220 FILED AS OF DATE: 20181220 DATE AS OF CHANGE: 20181220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KAMADA LTD CENTRAL INDEX KEY: 0001567529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35948 FILM NUMBER: 181244689 BUSINESS ADDRESS: STREET 1: 2 HOLTZMAN ST., SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 7670402 BUSINESS PHONE: 97289406472 MAIL ADDRESS: STREET 1: 2 HOLTZMAN ST., SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 7670402 6-K 1 zk1822390.htm 6-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934

For the Month of December, 2018

Commission File Number 001-35948

Kamada Ltd.
(Translation of registrant’s name into English)
 
2 Holzman Street
Science Park, P.O. Box 4081
Rehovot 7670402
Israel
 (Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒          Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐          No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82‑____
 
This Form 6-K is being incorporated by reference into the Registrant's Form S-8 Registration Statements, File Nos. 333-192720, 333-207933 and 333-215983, and the Registrant's Form F-3 Registration Statement, as amended, File No. 333-214816.
 

 


 
The following exhibits are attached:

99.1
Notice of Results of the 2018 Annual General Meeting of Shareholders, held on December 20, 2018
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:  December 20, 2018
KAMADA LTD.
 
 
 
By:   /s/ Orna Naveh
 
 
Orna Naveh
General Counsel and Corporate Secretary
 
 
 

 
EXHIBIT INDEX
 
EXHIBIT NO.
DESCRIPTION
   

 


 
EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1

 
EXHIBIT 99.1

KAMADA LTD.
2 Holzman Street
Weizmann Science Park
P.O. Box 4081
Rehovot 7670402, Israel

Notice of Results of the 2018 Annual General Meeting of Shareholders, held on December 20, 2018

Kamada Ltd. (the "Company") today announced that all of the proposals presented for approval at its 2018 Annual General Meeting of Shareholders held on December 20, 2018 in Rehovot, Israel (the "Meeting") were duly approved by the shareholders of the Company.  Accordingly, at the Meeting, the shareholders of the Company approved the following:
 
1.
The election of the following directors to serve as members of the Company’s Board of Directors until the next annual general meeting of shareholders:
 
Mr. Leon Recanati
Dr. Michael Berelowitz
Mr. Avraham Berger
Mr. Jonathan Hahn
Mr. Asaf Frumerman
Prof. Itzhak Krinsky
Ms. Efrat Makov
Mr. Shmuel (Milky) Rubinstein
Mr. David Tsur
 
2.
The Company entering into an indemnification and exculpation agreement with Ms. Efrat Makov, as detailed in the Proxy Statement filed by the Company on November 7, 2018 (the "Proxy Statement").
 
3.
The grant of options to each of the director nominees (other than Mr. Asaf Frumerman), as detailed in the Proxy Statement.
 
4.
The amended compensation terms and a one-time award of equity-based compensation, consisting of options and restricted shares, to Mr. Amir London, the Company’s Chief Executive Officer, as detailed in the Proxy Statement.
 
5.
The amendment to the Company’s Compensation Policy for Executive Officers and Directors, with respect to the maximum side “A” directors’ and officers’ liability coverage, as detailed in the Proxy Statement.
 
6.
The ratification and approval of the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent registered public accountants for the year ending December 31, 2018 and for such additional period until the next annual general meeting.